ARCHIVES

Nancy Brinker Resigns As CEO of Komen

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

September 24, 1999

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977